Research and Markets: Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2012

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/qnfwbw/chemotherapy) has announced the addition of Global Markets Direct's new report "Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2012" to their offering.

This report provides information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Nausea and Vomiting. Chemotherapy Induced Nausea and Vomiting - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Chemotherapy Induced Nausea and Vomiting.

- A review of the Chemotherapy Induced Nausea and Vomiting products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Chemotherapy Induced Nausea and Vomiting pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Involved in Chemotherapy Induced Nausea and Vomiting Therapeutics Development

- BioDelivery Sciences International, Inc.

- Merck & Co., Inc.

- A.P. Pharma, Inc.

- Aphios Corporation

- Axcan Pharma Inc.

- Dr. Reddy's Laboratories Limited

- IntelGenx Technologies Corp.

- ProStrakan Group plc

- AGI Therapeutics plc

- Teikoku Pharma USA, Inc.

- SymBio Pharmaceuticals Limited

- INSYS Therapeutics, Inc.

- Helsinn Healthcare S.A.

- Shin Nippon Biomedical Laboratories, Ltd.

- Almac Discovery Ltd.

- Acacia Pharma Ltd.

For more information visit http://www.researchandmarkets.com/research/qnfwbw/chemotherapy

Source: Global Markets Direct

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology